Mechanism of Action: Monoamine Oxidase Inhibitors
✉ Email this page to a colleague
Drugs with Mechanism of Action: Monoamine Oxidase Inhibitors
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bausch | ZELAPAR | selegiline hydrochloride | TABLET, ORALLY DISINTEGRATING;ORAL | 021479-001 | Jun 14, 2006 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
Strides Pharma | TRANYLCYPROMINE SULFATE | tranylcypromine sulfate | TABLET;ORAL | 040640-001 | Jun 29, 2006 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
Novitium Pharma | TRANYLCYPROMINE SULFATE | tranylcypromine sulfate | TABLET;ORAL | 206856-001 | Apr 17, 2018 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
Rising | SELEGILINE HYDROCHLORIDE | selegiline hydrochloride | CAPSULE;ORAL | 206803-001 | Apr 2, 2019 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
Apotex Inc | SELEGILINE HYDROCHLORIDE | selegiline hydrochloride | TABLET;ORAL | 074871-001 | Jun 6, 1997 | AB | RX | No | Yes | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |